John T. Wei

TL;DR: Primary care providers reported that prostate cancer survivorship care is prevalent in their practice, yet few felt very comfortable managing side effects of prostate cancer treatment, so quality of care plans across specialties, or transferring primary responsibility to primary care providers through survivorship guidelines should be considered.

TL;DR: To better risk stratify patients, using baseline characteristics, to help optimise decision‐making for men with moderate‐to‐severe lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) through a secondary analysis of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

TL;DR: In men with clinically localized prostate cancer who have undergone at least 1 previous negative biopsy and have elevated serum prostate‐specific antigen (PSA) levels, long‐term health outcomes associated with the assessment of urinary prostate cancer antigen 3 (PCA3) and the transmembrane protease, serine 2 (TMPRSS2) have not been investigated previously.

TL;DR: Results of the InSYNC questionnaire showed high levels of sexual concern among cancer survivors, and Prostate cancer survivors were most concerned about being able to satisfy their partners.

TL;DR: In this sample of urologic patients, prolonged LOS is associated with both preoperative and intraoperative factors, and efforts should be made to improve intraoperative processes and to minimize preoperative risk factors.